Tag: MPH

  Editor’s note — the following is a roundup of the news that made headlines at Vanderbilt University Medical Center in 2023.   Whole-genome sequencing agreement Nashville Biosciences LLC, a wholly owned subsidiary of Vanderbilt University Medical Center, and Illumina Inc., a global leader in DNA sequencing and array-based technologies,…

Faculty and trainees from the University of Chicago Medicine Comprehensive Cancer Center (UCCCC) joined the world’s largest hematology community to discuss the latest updates in blood cancers at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition held December 9-12, 2023 in San Diego and online. At the meeting,…

McLaren revealed a new model called the GTS, which is essentially a facelifted version of the GT. The GTS features the same twin-turbo 4.0-liter V-8, but now with 626 hp, a 14 hp bump. There are also new colors, wheels, and interior trim options. McLaren doesn’t usually deviate far from…

Karuna Therapeutics, Inc. (NASDAQ: KRTX) today announced that results from the Phase 3 EMERGENT-2 trial of KarXT (xanomeline-trospium) in adults with schizophrenia were published in The Lancet. The manuscript shares KarXT data showcasing a clinically meaningful and statistically significant reduction in positive and negative symptoms of schizophrenia among adult patients…

The 2024 Ford Mustang is available in a multitude of different trims, each of which touts its own benefits. The EcoBoost Fastback provide excellent value for money, while the Dark Horse Mustang provides owners with the ultimate muscle car driving experience. HOTCARS VIDEO OF THE DAY SCROLL TO CONTINUE WITH…

The National Weather Service in Miami issued a flood watch Wednesday for large parts of South Florida while forecasters warned gusty winds plaguing the region over the next several days could blow away your holiday decorations. Flooding is possible in the coastal and metropolitan areas of Miami-Dade, Broward and Palm…

Two men walk through a flood at West 14th Avenue and West 29 Street in Hialeah on Thursday, Nov. 16, 2023. Pedro Portal pportal@miamiherald.com The National Weather Service in Miami issued a flood watch Wednesday for large parts of South Florida while forecasters warned gusty winds could blow away your…

Patients with relapsed diffuse large B cell lymphoma (DLBCL) who achieve a complete remission from interim chemotherapy while awaiting secondary chimeric antigen receptor (CAR) T cell therapy show significantly better outcomes if they then receive conventional autologous stem cell transplantation (auto-HCT), compared with CAR T therapy. “In patients with relapsed…

The federal employee vaccine requirement was rescinded by President Joe Biden in May, and the Pentagon similarly withdrew a mandate for troops, but cases challenging the mandate for executive branch employees and military service members had rumbled on. CNN: Covid-19 Vaccine Mandates For Executive Branch Employees And Troops Thrown Out…

© Jackie Niam – stock.adobe.com Physicians will help a national group guide American health care policy for virtual care. The American Telemedicine Association (ATA) announced a new Clinician Council “to address barriers to the broad adoption of telehealth and virtual care delivery, including emerging platforms that support technology-enabled health care.” The…

The Hyundai Ioniq 5 is the South Korean brand’s premier electric crossover, which launched the all-electric Ioniq portfolio in the U.S. The mid-size SUV in electric cars neatly balances futuristic aesthetics with contemporary design cues. It creates a unique-looking product that stays close to conventional car designs. TOPSPEED VIDEO OF…

Patients with relapsed diffuse large B cell lymphoma (DLBCL) who achieve a complete remission from interim chemotherapy while awaiting secondary chimeric antigen receptor (CAR) T cell therapy show significantly better outcomes if they then receive conventional autologous stem cell transplantation (auto-HCT), compared with CAR T therapy. “In patients with relapsed…

This transcript has been edited for clarity. Michelle L. O’Donoghue, MD, MPH: Hi. This is Dr Michelle O’Donoghue, reporting for Medscape. I’m here at the American Heart Association meeting, and one of the interesting stories that we’re going to be talking about is that of gene editing. Joining me to…

The word “ludicrous” means so foolish, unreasonable, or out of place as to be amusing or ridiculous. Considering this definition, does it make sense that Elon Musk used this term to describe the high-performance mode of Tesla’s electric vehicles? Absolutely. The eccentric CEO gave us Ludicrous Mode and Ludicrous+ Mode…

Mini is fortifying its electrified lineup for 2025 and the Cooper SE JCW is its newest offering. With 215 hp and 243 lb-ft of torque, Mini has only confirmed the Cooper SE JCW for the European market. The electric hot hatch shows what the future of Mini’s JCW performance branch…

You’re familiar with the term “early adopter,” right? The people who jump on something new as soon as possible, be it a piece of hardware, a type of software, or what have you. While hopping on the bandwagon early sometimes grants knowledge and status, it can also backfire because early…

PrEPVacc, the only current large HIV vaccine study, has been halted ahead of schedule because “there is little or no chance of the trial demonstrating vaccine efficacy in preventing HIV acquisition,” according to a December 6 announcement. Trial leaders shared the news at the International Conference on AIDS and STIs…

The JCW Trim version of the Cooper SE retains the standard model’s 215 hp electric motor and has the same 250 miles of range www.carscoops.com/author/bradcarscoops-com/ by Brad Anderson 6 hours ago We have good news for those who want to pick up the keys to the new Mini Cooper S,…

PARSIPPANY, N.J. & SAN DIEGO–(BUSINESS WIRE)– Melinta Therapeutics, LLC and Cidara Therapeutics, Inc. (NASDAQ: CDTX) today announced the peer-reviewed publication of pooled data from two completed global clinical trials evaluating REZZAYO® (rezafungin for injection) for the treatment of candidemia and invasive candidiasis. The article, “Efficacy and safety of rezafungin and…

FDA Launches Priority Review of Enfortumab Vedotin Plus Pembrolizumab in Advanced Urothelial Cancer The supplemental biologics license application (sBLA) for enfortumab vedotin-ejfv (Padcev) plus pembrolizumab (Keytruda) has received priority review from the FDA. The combination is being considered as frontline treatment for patients with locally advanced or metastatic urothelial cancer. The…

The difference between the current least expensive and most expensive Cybertruck trims is $39,000 — and more so if you factor in the $7,500 tax credit that comes with the former. However, that higher price might be worth it to you if you’re looking for more speed, power, and range….

Supporting data for the sBLA came from the phase 3 EV-302/KEYNOTE-A39 trial (NCT04223856), in which the pembrolizumab combination significantly extended the primary endpoints of overall survival (OS) and progression-free survival (PFS) in patients with locally advanced or metastatic urothelial cancercompared withstandard platinum-containing chemotherapy. The FDA has given priority review to…

November 30, 2023 By Not a Tesla App Staff Tesla just finished its Cybertruck delivery event and has now announced final specs and pricing for its three Cybertruck variants. Specifications and Prices RWD Cybertruck Estimated Price: $60,990 Availability: 2025 Estimated Range: 250 miles Acceleration: 0-60 mph in 6.5 seconds AWD…

No, your eyes are not deceiving you. The Tesla Cybertruck is finally here. The production-spec electric pickup was revealed at an event at Tesla’s Gigafactory in Austin, Texas, that was livestreamed on X, formerly known as Twitter. CEO Elon Musk started off the event by proclaiming, “You have a car…

Breadcrumb Trail Links Preview Pickup trucks New Vehicles Electric Vehicles Turns out a “Cyberbeast” trim will apparently offer more than 700 km on a charge thanks to a range extender Published Nov 30, 2023  •  Last updated 1 day ago  •  4 minute read The Tesla Cybertruck on display at the…

Tesla has finally revealed the pricing, range, trims, and other specifications of the Cybertruck at its delivery event at Gigafactory Texas today, as it handed over the first units to customers on Thursday afternoon. After four years, Tesla finally made the first deliveries of the Cybertruck in what will be…

Recommended Sponsor Painted-Moon.com – Buy Original Artwork Directly from the Artist Source: US Food and Drug Administration-1 A person commits a crime, and the detective uses DNA evidence collected from the crime scene to track the criminal down. An outbreak of foodborne illness makes people sick, and the U.S. Food…

CANADA – Medicure Inc. (‘Medicure‘ or the ‘Company’) (TSXV: MPH, OTC: MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today announced that the FDA provides complete approval to enroll patients in its pivotal Phase 3…

WINNIPEG, MB / ACCESSWIRE / November 23, 2023 / Medicure Inc. (‘Medicure‘ or the ‘Company‘) (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today announced that the FDA provides complete approval to enroll patients…

Quotient’s Somatic Genomics platform reveals new approaches to treat disease based on the vast genetic variation present in the body’s trillions of cells Company emerges from stealth after two years of platform development with an initial commitment of $50 million from Flagship Pioneering CAMBRIDGE, Mass., Nov. 21, 2023 /PRNewswire/ —…

Arnab Basu, MD, MPH Assistant Professor UAB Medicine Birmingham, AB DISCUSSION QUESTIONS From the TIVO-3 (NCT02627963) data set, what efficacy parameters appeal about tivozanib (Fotivda)? What role is there for sustained VEGF inhibition in the relapsed/refractory renal cell carcinoma (RCC) setting? ARNAB BASU, MD, MPH: From all the data that…

Findings from the phase 3 DUO-E/GOG-3041/ENGOT-EN10 trial (NCT04269200)—assessing combination chemotherapy/durvalumab (Imfinzi), single-agent durvalumab, and durvalumab/olaparib (Lynparza) in patients with newly diagnosed advanced or recurrent endometrial cancer—were “exciting,” according to Shannon N. Westin, MD, MPH, FACOG. In a conversation with CancerNetwork® during the 2023 Annual Global Meeting of the International Gynecologic…

MU School of Medicine students presented roughly 250 research projects at the annual 2023 Health Sciences Research Day (HSRD), held Nov. 10, 2023, and featured the work of undergraduates, medical and nursing students, PhD students and postdoctoral trainees. The research posters covered a variety of topics within the health care…

Both MPH and ATX increase the locomotor activity of wild-type Drosophila To investigate the cell type-specific molecular mechanisms of ADHD drugs in the brain at single-cell resolution, we conducted behavioral experiments and scRNASEQ in wild-type (WT) adult male Drosophila melanogaster following exposure to MPH, ATX, and control treatment. Here, we…

Sara M. Tolaney, MD, MPH, chief of the Division of Breast Oncology and associate director of the Susan F. Smith Center for Women’s Cancers, senior physician at Dana-Farber Cancer Institute, and associate professor of medicine at Harvard Medical School, all in Boston, Massachusett In a rapidly evolving field, new strides…

Alzheimer’s disease is more than a neurodegenerative disorder. For the 6 million people living with the disease1 (and their caregivers), mild, moderate or severe symptoms are the cause of lost memories, forgotten faces, declines in reasoning and poor decision-making.2 Since 2021, pivotal trials that demonstrated some clinical benefit led to…

Highlights Karina Ascunce González graduated from Harvard University in May 2022 with an A.B. in Neuroscience and a secondary in Global Health & Health Policy Karina is currently a PhD Student in Biological and Biomedical Sciences, Neuroscience Track at Yale University. In addition to her PhD research, Karina is conducting…

Key Points Question  Is clonal hematopoiesis of indeterminate potential (CHIP) detected at the time of hematopoietic stem transplant (HCT) associated with increased rates of cardiovascular disease (CVD) among patients with multiple myeloma (MM) following HCT? Finding  In this cohort study of patients with MM undergoing HCT, CHIP was highly prevalent…

Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous system (CNS) disorders, today announced the Company will present at two upcoming scientific conferences in November. “Vistagen’s presentations highlight the significant progress we have made to…

In the first analysis of longer-term data in children aged 1 to 11 years with eosinophilic esophagitis (EoE), a higher dose of Dupixent (dupilumab) was shown safe and effective for up to one year in a phase 3 trial. The results were presented at the American College of Gastroenterology 2023…

For a long time, surgery was the only real treatment option available for melanoma, but there are new therapies that have significantly improved outcomes, at a cost. During an Institute for Value-Based Medicine event in Minneapolis, Minnesota, cohosted by The American Journal of Managed Care and Minnesota Oncology, a group…

In hospitalized adult patients, RSV diagnosis is typically assessed on PCR testing using nasopharyngeal (NP) swabs. This can be problematic for 2 reasons explains Elizabeth Begier, MD, MPH, senior director, scientific affairs lead, RSV Antiviral/Adult Vaccine Program, Pfizer Vaccines. “The two primary challenges are first that RSV is actually infrequently…

In an interview with Peers and Perspectives in Oncology, Tim Showalter, MD, MPH, vice president of clinical development at ArteraAI and professor in the Radiation Oncology Department at the University of Virginia School of Medicine, discussed increasing patient quality of life (QOL) by using artificial intelligence (AI) and precision medicine…

Combined Therapeutics to Present at 11th International mRNA Health Conference Details Category: DNA RNA and Cells Published on Thursday, 26 October 2023 11:46 Hits: 620 Dr. Romain Micol, President and Chief Executive Officer, will provide an update on Combined Therapeutics’ proprietary MOPCTx mRNA platform, which controls where the protein is…

Caris Life Sciences®(Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition using molecular science and AI, today announced a new agreement with Moderna (NASDAQ: MRNA) in support of Moderna’s oncology and novel…

Partnership enables Moderna to leverage Caris’ vast library of de-identified, multi-modal data and analytics capabilities to accelerate precision medicine and the delivery of novel medicines to patients IRVING, Texas, Oct. 24, 2023 /PRNewswire/ — Caris Life Sciences®(Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively…

A parasitic disease that can cause skin ulcers and is usually spread by the tiny sandfly may now be endemic to the U.S., preliminary findings from CDC researchers suggested. Genetic sequencing of 2,235 U.S. cutaneous leishmaniasis samples submitted from 2005 to 2019 confirmed the presence of a potentially distinct genotype…

Shannon N. Westin, MD, MPH, FACOG The addition of durvalumab (Imfinzi) to first-line chemotherapy, followed by maintenance treatment with durvalumab plus olaparib (Lynparza) significantly improved progression-free survival (PFS) in patients with newly diagnosed advanced or recurrent endometrial cancer, according to data from the phase 3 DUO-E/GOG-3041/ENGOT-EN10 trial (NCT04269200) presented at…

The addition of durvalumab (Imfinzi) to first-line chemotherapy, followed by maintenance therapy with the anti-PD-L1 antibody plus olaparib (Lynparza) improved progression-free survival (PFS) in patients with newly diagnosed advanced or recurrent endometrial cancer, according to data from the phase 3 DUO-E/GOG-3041/ENGOT-EN10 trial (NCT04269200) presented at ESMO Congress 2023.1-3 In particular,…

By Matthew StengerPosted: 10/19/2023 12:17:00 PM Last Updated: 10/19/2023 1:59:52 PM In a prospective cohort study (PATHFINDER) reported in The Lancet, Deb Schrag, MD, MPH, FASCO, and colleagues evaluated the performance of blood-based testing for multicancer early detection in adults without signs or symptoms of cancer.  As stated by the…

October 19, 2023 1 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . “ data-action=”subscribe”> Subscribe We were unable to process…

Credit: Unsplash/CC0 Public Domain Today, nearly 900 disorders caused by a single gene are known to be treatable. Yet the recommended “heel stick” testing for newborns only covers about 60 inherited, treatable disorders, and many individual states screen for fewer. What if newborns could instead have their entire genome sequenced…

BOSTON – Novel treatments, combination therapies, and personalized medicine headline several studies led by Dana-Farber Cancer Institute and presented for the first time at the European Society of Medical Oncology (ESMO) Congress 2023 in Madrid, Spain. The studies will be presented both in-person and online on October 20-24, 2023. A…

Jonathan Silverberg, MD Credit: gwdocs.com The drug upadacitinib may be safe and effective long-term in treating patients with moderate-to-severe atopic dermatitis (AD) across 140 weeks, according to new data presented at the 32nd European Academy of Dermatology and Venereology (EADV) Congress in Berlin.1 These findings, announced by AbbVie from EADV,…

Mehrdad Mobasher, MD, MPH The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of zanubrutinib (Brukinsa) in combination with obinutuzumab (Gazyva) for use in adult patients with relapsed or refractory follicular lymphoma who have previously received at least 2 lines of systemic treatment.1…

SAN DIEGO – Radiation has become a crucial component of treatment for diffuse large B cell lymphoma (DLBCL) over the past 25 years. But radiologists presenting at an annual conference cautioned colleagues to keep the limitations of radiology in mind and not to assume that it’s always a necessary adjunct…

Nemolizumab may lead to substantial improvements for those with prurigo nodularis (PN) and atopic dermatitis (AD), according to new phase 3 data presented at the 2023 European Academy of Dermatology and Venereology (EADV) congress in Berlin.1 These findings were announced by Galderma, with 3 studies yielding positive results for both…

DELFI leadership to announce advancement with whole-genome machine learning for lung cancer detection test at HLTH 2023; Presentation of DELFI’s L101 clinical validation study at CHEST Annual Meeting BALTIMORE and PALO ALTO, Calif., Oct. 4, 2023 /PRNewswire/ — DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a…

The groundbreaking BabySeq study has a new initiative: making genomic sequencing accessible to a more diverse population of newborns. (Images: AdobeStock, Illustration: Sebastian Stankiewicz, Boston Children’s Hospital) Today, nearly 900 disorders caused by a single gene are known to be treatable. Yet the recommended “heel stick” testing for newborns only…

V. cholerae in Yemen in 2018 and 2019 The National Centre of Public Health Laboratories (NCPHL) in Sana’a, the capital city of Yemen, received 6,311 and 3,225 clinical samples from suspected cholera patients in 2018 and 2019, respectively (Supplementary Table 1). Of these, 2,204 (35%) and 2,171 (67%) were confirmed…

Newly announced long-term follow-up data from Regimen C of the HEALEY ALS platform trial (NCT04297683) assessing the investigational agent CNM-Au8 (Clene Nanomedicine) in patients with amyotrophic lateral sclerosis (ALS) showed a decreased risk of mortality for up to 133 weeks in treated patients compared with placebo-treated patients from the Pooled…

Douglas W. Sborov, MD, MS (MODERATOR) Associate Professor, Division of Hematology and Hematologic Malignancies Department of Internal Medicine University of Utah School of Medicine Huntsman Cancer Institute Salt Lake City, UT EVENT REGION Arizona, Colorado, New Mexico, Utah PARTICIPANT LIST Christopher Chen, MD | Muhammad Anas Tarajki, MD | Darshil…

Arcutissubmits roflumilast 0.15% sNDAfor AD in children 6 years and up | Image Credit: © lial88 – © lial88 – stock.adobe.com. A supplemental New Drug Application (sNDA) has been submitted to the FDA by Arcutis Biotherapeutics for roflumilast cream 0.15%, a steroid-free, once-daily topical to treat mild to moderate atopic…

Postdoctoral Associate in Bioinformatics Job No: 528604Work Type: Post Doc AssociateLocation: Main Campus (Gainesville, FL)Categories: Grant or Research Administration, Health Care Administration/Support, Physical/Mathematical SciencesDepartment: 36010000 – PHHP-COM BIOSTATISTICS Job Description Classification Title: Postdoctoral Associate Job Description: Dr. Li Chen’s laboratory (lichen-lab.github.io/) at the University of Florida’s Department of Biostatistics (biostat.ufl.edu/)…

Topline data from Phase 3 trial expected in Q4 2024 Company to present encore 36-month efficacy, safety, and patient-reported outcomes data from the Phase 2 TOPAZ trial extension at the 2023 World Muscle Society (WMS) Annual Congress Apitegromab is the only muscle-targeted therapy candidate with clinical data showing proof of…

Biopharmaceutical company Arcutis Biotherapeutics announced the successful achievement of the primary and secondary endpoints of the INTEGUMENT-PED phase 3 study on roflumilast cream 0.05% for those in the age range of 2 to 5 years with mild-to-moderate atopic dermatitis (AD).1 Roflumilast cream 0.05% is a steroid-free topical cream that is…

Apnimed, Inc. – Seasoned biopharma medical leader joins Apnimed as it initiates its Phase 3 clinical program for AD109, a potential new oral treatment for Obstructive Sleep Apnea John Yee, MD, MPH John Yee, MD, MPH, Senior Vice President of Medical Affairs, Apnimed CAMBRIDGE, Mass., Sept. 18, 2023 (GLOBE NEWSWIRE)…

Rapid GS workflow and summary of genetic diagnoses. (A) Rapid GS workflow and time intervals, created with BioRender.com. (B) Genetic diagnoses arranged by age at seizure onset. Each square represents an infant who received a genetic diagnosis. The affected gene or genomic region is denoted in the square. The infant…

FDA Approves Updated COVID-19 Vaccines On Monday, the FDA approved 2 updated COVID-19 booster vaccines for people as young as 6 months, according to STAT. This may result in Moderna and Pfizer-BioNTech vaccines becoming available in doctors’ offices, clinics, and pharmacies later in the week. The Advisory Committee on Immunization…

Rapid GS workflow and summary of genetic diagnoses. (A) Rapid GS workflow and time intervals, created with BioRender.com. (B) Genetic diagnoses arranged by age at seizure onset. Each square represents an infant who received a genetic diagnosis. The affected gene or genomic region is denoted in the square. The infant…

This is an installment of Good Fit, a column about exercise. Though Antonella Avogadro’s job as a software engineer normally ties her to her desk for most of the day, she still manages to get in about 10,000 steps—and sometimes even up to 20,000 steps—before clocking out. On the days she…

Raymond Mailhot Vega, MD, MPH More aggressive axillary surgery was not associated with improved outcomes in patients with cN1 breast cancer that became ycN0 but remained node positive following neoadjuvant chemotherapy, according to findings from a retrospective analysis of patients treated in the phase 3 NSABP B-40 (NCT00408408) and NSABP…

An outbreak of multidrug-resistant tuberculosis (TB) developed in Kansas in November 2021, and included multiple children who were born in the U.S. and became infected in the state, CDC researchers reported. The outbreak involved 13 people across four households in Kansas City and spanned 1 year. While a majority of…

Acinetobacter pittii is a crucial pathogen that mainly causes healthcare-associated infections, including pneumonia, bloodstream infections (BSIs) and urinary tract infections (UTIs).1 Carbapenem-resistant A. pittii (CRAP) poses a huge challenge in clinical settings. CRAP is increasingly recognized as a significant pathogen of hospital-acquired infections in the hospital.2 Carbapenem resistance in A….

Interim data from the phase 3 CABINET trial (NCT03375320) demonstrated significant improvement in progression-free survival (PFS) with cabozantinib (Cabometyx) vs placebo in patients with advanced pancreatic or extra-pancreatic neuroendocrine tumors (NETs) following progression on prior systemic therapy. As such, the trial will be unblinded and discontinued following a unanimous decision…

Study Title: Allogeneic Hematopoietic Cell Transplantation Improves Outcome in MDS across High-Risk genetic subgroups: Genetic analysis of the BMT CTN 1102 study Publication: Journal of Clinical Oncology, Click here for link Dana-Farber Authors: Jurjen Versluis, MD; Christopher J. Gibson, MD; Corey Cutler, MD, MPH, FRCPC; R. Coleman Lindsley, MD, PhD…

CASE SUMMARY A 62-year-old woman presented with a 6 cm right breast mass, which has been slowly growing for 1 year with palpable axillary nodes​. Her liver function test was within normal limits and a CT scan showed 2 liver nodules, with the largest being 2 cm​. A bone scan showed…

The Department of Epidemiology and Biostatistics, at The University of Maryland School of Public Health, College Park (www.sph.umd.edu/EPIB) invites applications for a tenure-track Assistant Professor position in Epidemiology.    The Department’s mission is to improve health and reduce health disparities in local communities, the state of Maryland, and the nation….

A recent outbreak of Salmonella Typhimurium infections in Ontario, Canada had an unprecedented link to a plant-based protein, researchers found. From May to mid-August of 2021, public health and food safety authorities investigated a cluster of 38 patients across multiple public health districts in Ontario; five patients were hospitalized, though…

Brad Haverkos, MD, MPH, MS Associate Professor, Medicine-Hematology University of Colorado School of Medicine Aurora, CO DISCUSSION QUESTIONS How has the approval of loncastuximab tesirine (Zynlonta) addressed an unmet need in the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL)? ​ In which patient population is loncastuximab most suitable for? ​ Are there any instances…

Introduction: Mitochondria are increasingly recognized to play a role in the airway inflammation of asthma. Model systems to study the role of mitochondrial gene expression in bronchial epithelium are lacking. Here, we create custom bronchial epithelial cell lines derived from primary airway epithelium that are depleted of mitochondrial DNA. Methods:…

The safety and efficacy of zipalertinib (CLN-081, TAS6417) plus platinum-based chemotherapy will be compared with platinum-based chemotherapy alone in patients with treatment-naïve, locally advanced or metastatic non–small cell lung cancer (NSCLC) harboring EGFR exon 20 insertion mutations in the phase 3 REZILIENT3 trial (NCT05973773).1 Previously, results from a phase 1/2a…

Developers designed the orally available small molecule zipalertinib as an irreversible EGFR inhibitor for treating a genetically defined group of patients with NSCLC. Developers have initiated the phase 3 REZILIENT3 trial (NCT05973773) to assess zipalertinib (CLN-081/TAS6417) plus chemotherapy as a frontline treatment option for adult patients with EGFR exon 20…

Elevar Therapeutics FORT LEE, N.J., Aug. 03, 2023 (GLOBE NEWSWIRE) — Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options, today announced it will host a virtual…

The CDC’s ACIP voted today to recommend nirsevimab-alip (Beyfortus) for the protection against severe respiratory syncytial virus (RSV) in the first respiratory virus season for all infants and for a second season for those who remain at increased risk for severe RSV. Specifically, the ACIP committee voted on the following…

ROCKVILLE, Md.–(BUSINESS WIRE)– GlycoMimetics, Inc. (Nasdaq: GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today reported its financial results and highlights for the second quarter ended June 30, 2023. Cash and cash equivalents as of June 30, 2023 were $58.0 million. “With the…

Brad Haverkos, MD, MPH, MS Associate Professor, Medicine-Hematology University of Colorado School of Medicine Aurora, CO CASE SUMMARY: A 73-year-old woman presented with fever, headaches, and 7-lb unintentional weight loss​. She is married with 2 grown children who live in other states; she is the primary caretaker for her mother who…

SEATTLE, July 28, 2023 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that the first patient with IgA nephropathy (IgAN) has been enrolled in the BEYOND study, a pivotal phase 3 clinical…

The official GUINNESS WORLD RECORDS title was achieved by driver Jake Hughes of NEOM McLaren Formula E Team who competed with ABB FIA Formula E World Championship rival, Mahindra Racing team driver Lucas di Grassi, to set the world record for the fastest speed achieved by a vehicle indoors. The…

By Dennis Thompson HealthDay Reporter TUESDAY, July 18, 2023 People with type 2 diabetes could soon have access to convenient once-a-week insulin shots that could replace the daily injections now required. A once-weekly insulin formulation called icodec performed just as well as daily doses of the insulin degludec, phase 3…

Continued research efforts have solidified the use of targeted therapies in hormone receptor (HR)–positive breast cancer and indicate the importance of further research with novel agents, such as HER3-directed antibody-drug conjugates (ADCs) in metastatic disease, according to Maryam Lustberg, MD, MPH. Among breast cancer data presented at the 2023 ASCO…

In Colorado and Wyoming, nearly every baby born since 2020 is tested for signs of a mutation in the SMN1 gene, an indicator of spinal muscular atrophy (SMA). And in 4 years, genetic counselor Melissa Gibbons has seen 24 positive results. She has prepped 24 different pediatricians and family doctors…

The study, “A Comparative Analysis of Rapid Whole Genomic Sequencing and a Targeted Neonatal Gene Panel in Infants with a Suspected Genetic Disorder: The Genomic Medicine for Ill Neonates and Infants (GEMINI) Study,” was first published online in ). Funded by the National Institutes of Health, the first-of-its-kind GEMINI Study…

The FDA has accepted a supplemental biologics license application (sBLA) seeking the approval of zanubrutinib (Brukinsa) in combination with obinutuzumab (Gazyva) in the treatment of adult patients with relapsed/refractory follicular lymphoma who received at least 2 prior lines of therapy.1 The sBLA is supported by data from the phase 2…

A new national study, led by researchers at Tufts Medical Center in Boston, has found whole genome sequencing (WGS) to be nearly twice as effective as a targeted gene sequencing test at identifying abnormalities responsible for genetic disorders in newborns and infants. The study, “A Comparative Analysis of Rapid Whole…

A new national study, led by researchers at Tufts Medical Center in Boston, has found whole genome sequencing (WGS) to be nearly twice as effective as a targeted gene sequencing test at identifying abnormalities responsible for genetic disorders in newborns and infants. The study, “A Comparative Analysis of Rapid Whole…

A new national study, led by researchers at Tufts Medical Center in Boston, has found whole genome sequencing (WGS) to be nearly twice as effective as a targeted gene sequencing test at identifying abnormalities responsible for genetic disorders in newborns and infants. The study, “A Comparative Analysis of Rapid Whole…

July 11, 2023 (BOSTON) – A new national study, led by researchers at Tufts Medical Center in Boston, has found whole genome sequencing (WGS) to be nearly twice as effective as a targeted gene sequencing test at identifying abnormalities responsible for genetic disorders in newborns and infants. The study, “A…

Whole genome sequencing captured almost twice as many genetic abnormalities that may be responsible for disease in infants, compared with a standard targeted test, researchers found. In the Genomic Medicine for Ill Neonates and Infants (GEMINI) study, the diagnostic yield of whole genome sequencing was 49%, compared with 27% with…

A national study, led by researchers at Tufts Medical Center, has found whole genome sequencing (WGS) to be nearly twice as effective as a targeted gene sequencing test at identifying abnormalities responsible for genetic disorders in newborns and infants. The Genomic Medicine in Ill Infants and Newborns (GEMINI) study did,…